Purchase Order 75N92023P00284
Award Date 8/25/23
Potential Completion Date 8/25/24
Potential Value $64K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
- This contract award to Pacific Biosciences of California, Inc. is for the delivery of a PacBio RS II DNA Sequencer System to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $627,500 firm-fixed-price contract has a completion date of July 31, 2014. As the original equipment manufacturer, Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to federal agencies. The company has been...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. to provide SEQUEL II SEQUENCING KIT 2.0 BUNDLE. The contract has a potential value of $118,381.00 and a completion date of December 31, 2022. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The company has...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Pacific Biosciences of California, Inc. on July 19, 2018 for the provision of a PacBio Sequel DNA sequencer. The potential value of the contract is $337,500.00. Pacific Biosciences is a manufacturer and provider of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA...
- This federal contract award to Pacific Biosciences of California, Inc. has a ceiling value of $93,401.00 and was issued by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH). The purpose of this Firm Fixed Price purchase order is to procure Pacific Biosciences reagents for use by the NIH Intramural Sequencing Center. This award was not set aside for any specific business category. Pacific Biosciences is the prime contractor, and they...
- This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
- This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $480,000.00 firm-fixed price contract to Pacific Biosciences of California, Inc. to provide a Sequel II DNA/RNA sequencing system and associated services. The contract is for the purchase and delivery of the sequencing system and on-site training, with a trade-in of a previous Sequel I system. This contract is not set aside for any small business program....
- Pacific Biosciences of California, Inc. was awarded a $53,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide a Sequel II instrument service contract with insight from August 15, 2023 through August 14, 2024. The contract will deliver service and support for Pacific Biosciences' Sequel II sequencing systems to assist the agency's genomic research efforts. No set aside designation or subcontractors were identified. The...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a small business manufacturer of scientific equipment and reagents. The $227,225 contract provides NIAID's Vaccine Research Center with specialized single-molecule real-time (SMRT) sequencing kits and consumables, including SMRT cells, barcoded adapters, and binding reagents for their Sequel II DNA...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August 2025 through August 2026 to provide sequencing consumables for the NIH-NHLBI's genomic research programs. No subcontractors or set-aside designations were indicated.
Generated 12/19/23, 5:58 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.8k | 8/14/23 |